Live CoolSculpting(R) Demonstration With New CoolSmooth(TM) Applicator at the Aesthetic Meeting 2014
April 24 2014 - 8:00AM
Marketwired
Live CoolSculpting(R) Demonstration With New CoolSmooth(TM)
Applicator at the Aesthetic Meeting 2014
PLEASANTON, CA--(Marketwired - Apr 24, 2014) - ZELTIQ®
Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company
focused on developing and commercializing products utilizing its
proprietary controlled-cooling technology platform, today announced
it is exhibiting at The Aesthetic Meeting, organized by the
American Society for Aesthetic Surgery (ASAPS), in San Francisco,
April 24-29, 2014. Developed by ZELTIQ, the CoolSculpting
procedure is a non-surgical, clinically proven procedure designed
to selectively reduce fat in treated areas using a patented cooling
technology. Live CoolSculpting treatments will be performed in
the company's booth using the newly launched CoolSmooth applicator,
which delivers surface-based cooling to treat non-pinchable fat
bulges in areas such as the outer thigh.
Earlier this month, ZELTIQ announced that the U.S. Food and Drug
Administration cleared the CoolSculpting procedure for non-invasive
fat reduction of the thigh. The procedure is already U.S.
FDA-cleared for the abdomen and flank.
WHAT: CoolSculpting Procedure and CoolSmooth Applicator
Demonstration ZELTIQ Aesthetics, Booth #1413
WHEN: Saturday, April 26, 2014, 1:00 p.m. Sunday, April 27,
2014, 9:15 a.m. Monday, April 28, 2014, 1:25 p.m.
WHERE: The Aesthetic Meeting Moscone Center 747 Howard Street
San Francisco, CA 94103
About the CoolSculpting® Procedure The CoolSculpting procedure
is a non-surgical, clinically proven procedure that selectively
reduces fat bulges in problem areas using a patented cooling
technology. Cleared by the FDA for noninvasive fat reduction in the
abdomen, flank and thigh, it gently cools unwanted fat cells in the
body to induce a natural, controlled elimination of fat cell
without harming surrounding tissue, and the treated fat cells are
gone for good. Over 1,000,000 CoolSculpting cycles and 2,200
systems have been shipped to more than 60 countries. The
CoolSculpting procedure is available through an elite network of
CoolSculpting Centers worldwide. Dermatologists, plastic surgeons
and leading aesthetic specialists that offer CoolSculpting can be
found at www.coolsculpting.com.
Be sure to follow CoolSculpting on Facebook, Twitter, Pinterest
and YouTube.
About ZELTIQ® Aesthetics, Inc. ZELTIQ Aesthetics, Inc. is a
medical technology company focused on developing and
commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ's first
commercial product, the CoolSculpting system, is designed to
selectively reduce stubborn fat that may not respond to diet or
exercise. The CoolSculpting procedure is based on the
scientific principle that fat cells are more sensitive to cold than
the overlying skin and surrounding tissues. It utilizes
patented technology of precisely controlled cooling to reduce the
temperature of fat cells in the treated area, which is intended to
cause fat cell elimination through a natural biological process
known as apoptosis. ZELTIQ developed the CoolSculpting
procedure to safely, noticeably, and measurably reduce the fat
layer.
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zeltiq Aesthetics, Inc. (NASDAQ:ZLTQ)
Historical Stock Chart
From Jul 2023 to Jul 2024